Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis

INTRODUCTION: Randomized controlled trials (RCTs) comparing triple therapies (inhaled corticosteroid [ICS], long-acting β(2)-agonist [LABA], and long-acting muscarinic antagonist [LAMA]) for the treatment of chronic obstructive pulmonary disease (COPD) are limited. This network meta-analysis (NMA) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ismaila, Afisi S., Haeussler, Katrin, Czira, Alexandrosz, Youn, Ji-Hee, Malmenäs, Mia, Risebrough, Nancy A., Agarwal, Jatin, Nassim, Maria, Sharma, Raj, Compton, Chris, Vogelmeier, Claus F., Han, MeiLan K., Halpin, David M. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402726/
https://www.ncbi.nlm.nih.gov/pubmed/35849317
http://dx.doi.org/10.1007/s12325-022-02231-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402726/
https://www.ncbi.nlm.nih.gov/pubmed/35849317
http://dx.doi.org/10.1007/s12325-022-02231-0

Ejemplares similares